Εμφανίζονται 1 - 20 Αποτελέσματα από 121 για την αναζήτηση '"НЕВРОЛОГИЧЕСКИЕ НАРУШЕНИЯ"', χρόνος αναζήτησης: 0,84δλ Περιορισμός αποτελεσμάτων
  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
    Academic Journal
  7. 7
  8. 8
    Academic Journal

    Θέμα γεωγραφικό: USPU

    Relation: Специальное образование. 2022. № 2 (66)

    Διαθεσιμότητα: https://elar.uspu.ru/handle/ru-uspu/51070

  9. 9
    Academic Journal
  10. 10
  11. 11
    Academic Journal

    Πηγή: INTERNATIONAL NEUROLOGICAL JOURNAL; № 8.86 (2016); 53-62
    МЕЖДУНАРОДНЫЙ НЕВРОЛОГИЧЕСКИЙ ЖУРНАЛ; № 8.86 (2016); 53-62
    МІЖНАРОДНИЙ НЕВРОЛОГІЧНИЙ ЖУРНАЛ; № 8.86 (2016); 53-62

    Περιγραφή αρχείου: application/pdf

  12. 12
    Academic Journal

    Πηγή: HIV Infection and Immunosuppressive Disorders; Том 16, № 3 (2024); 25-35 ; ВИЧ-инфекция и иммуносупрессии; Том 16, № 3 (2024); 25-35 ; 2077-9828 ; 10.22328/2077-9828-2024-16-3

    Περιγραφή αρχείου: application/pdf

    Relation: https://hiv.bmoc-spb.ru/jour/article/view/933/601; Беляков Н.А., Халезова Н.Б., Боева Е.В., Рассохин В.В., Симакина О.Е., Незнанов Н.Г. Социальные ипсихологические проблемы вакцинации населения от новой коронавирусной инфекции // ВИЧ-инфекция и иммуносупрессии. 2021. Т. 13, № 3. С. 7–23 https://doi.org/10.22328/2077-9828-2021-13-3-7-23.; Беляков Н.А., Багненко С.Ф., Трофимова Т.Н., Рассохин В.В., Незнанов Н.Г., Тотолян А.А., Лобзин Ю.В., Симбирцев А.С., Дидур М.Д., Лиознов Д.А., Рыбакова М.Г., Колбин А.С., Харит С.М., Климко Н.Н., Пантелеев А.М., Стома И.О., Ястребова Е.Б. Последствия пандемии COVID-19. СПб.: Балтийский медицинский образовательный центр, 2022, 463 с. ISBN 978-5-6045822-5-1. РИНЦ EDN: DBIFYU.; Gorzalski A.J., Tian H., Laverdure C. et al. High-Throughput Transcription-mediated amplification on the Hologic Panther is a highly sensitive method of detection for SARS-CoV-2 // J. Clin. Virol. 2020. Nо. 129. P. 104501. doi:10.1016/j.jcv.2020.104501.; Finsterer J. Neurological side effects of SARS-CoV-2 vaccinations // Acta Neurol. Scand. 2022. Vol. 145, Nо. 1. P. 5−9. doi:10.1111/ane.13550.; Cines D.B., Bussel J.B. SARS-CoV-2 vaccine–induced immune thrombotic thrombocytopenia // N. Engl. J. Med. 2021. Vol. 384, Nо. 23. P.2254–2256. doi:10.1056/NEJMe2106315.; Diaz G.A., Parsons G.T., Gering S.K. et al. Myocarditis and pericarditis after vaccination for COVID-19 // JAMA. 2021. Vol. 326, Nо. 12. P.1210–1212. doi:10.1001/jama.2021.13443.; Ammirati E., Conti N., Palazzini M. et al. Fulminant Myocarditis Temporally Associated with COVID-19 Vaccination // Curr. Cardiol. Rep. 2024. Vol. 6, Nо. 3, P. 97–112. doi:10.1007/s11886-024-02021-w.; European Medicines Agency. COVID-19 vaccines: authorised. URL: www.ema.europa.eu/en/human-regulatory/overview/publichealththreats/coronavirus-disease-covid-19/treatments-vaccines/vaccines-covid-19/covid-19-vaccines-authorised#authorised-covid-19-vaccines-section.; Baden L.R., El Sahly H.M., Essink B. et al. Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine // N. Engl. J. Med. 2021. Vol. 384, Nо.5. P. 403–416. doi:10.1056/NEJMoa2035389.; Voysey M., Clemens S.A.C., Madhi S.A et al, Oxford COVID Vaccine Trial Group. Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK // Lancet. 2021. Vol. 397, Nо. 10269. P. 99–111. doi:10.1016/S0140-6736(20)32661-1.; Sadoff J., Gray G., Vandebosch A. et al. Safety and Efficacy of Single-Dose Ad26.COV2.S Vaccine against Covid-19 // N. Engl. J. Med. 2021. Vol. 384, Nо. 23. P. 2187–2201. doi:10.1056/NEJMoa2101544.; Li X., Ostropolets A., Makadia R. et al. Characterising the background incidence rates of adverse events of special interest for COVID-19 vaccines in eight countries: multinational network cohort study // BMJ. 2021. Nо. 373. n1435. doi:10.1136/bmj.n1435.; Center for Biologics Evaluation and Research Office of Biostatistics and Epidemiology. CBER Surveillance Program Background Rates of Adverse Events of Special Interest for COVID-19 Vaccine Safety Monitoring Protocol. 2020. URL: www.bestinitiative.org/wpcontent/uploads/2021/02/C19-Vaccine-Safety-AESI-Background-Rate-Protocol-FINAL-2020.pdf; Knoll M.D., Wonodi C. Oxford-AstraZeneca COVID-19 vaccine efficacy // Lancet. 2021. Vol. 397, Nо. 10269. P. 72–74. doi:10.1016/S0140-6736(20)32623-4.; Sadoff J., Le Gars M., Shukarev G. et al. Interim Results of a Phase 1–2a Trial of Ad26.COV2.S Covid-19 Vaccine // N. Engl. J. Med. 2021. Vol.384. Nо. 19. P. 1824–1835. doi:10.1056/NEJMoa2034201.; Marquez Loza A.M., Holroyd K.B., Johnson S.A. et al. Guillain-Barre Syndrome in the Placebo and Active Arms of a COVID-19 Vaccine Clinical Trial: Temporal Associations Do Not Imply Causality // Neurology. 2021. Vol. 96, Nо. 22. P. 1052–1054. doi:10.1212/WNL.0000000000011881.; Patone M., Handunnetthi L., Saatci D. et al. Neurological complications after first dose of COVID-19 vaccines and SARS-CoV-2 infection // Nat. Med. 2021, Vol. 27, N. 12. P. 2144–53. doi:10.1038/s41591-021-01556-7.; Langmuir A.D., Bregman D.J., Kurland L.T. et al. An epidemiologic and clinical evaluation of Guillain-Barré syndrome reported in association with the administration of swine influenza vaccines // Am. J. Epidemiol. 1984. Vol. 119, Nо. 6. P. 841–879. doi:10.1093/oxfordjournals.aje.a113809.; Salmon D.A., Proschan M., Forshee R. et al. Association between Guillain-Barré syndrome and influenza A (H1N1) 2009 monovalent inactivated vaccines in the USA: a meta-analysis // Lancet. 2013. Vol. 381, Nо. 9876. P. 1461–1468. doi:10.1016/S0140-6736(12)62189-8.; Arya D.P., Said M.A., Izurieta H.S. et al. Surveillance for Guillain-Barré syndrome after 2015–2016 and 2016–2017 influenza vaccination of Medicare beneficiaries // Vaccine. 2019. Vol. 37, Nо. 43. P. 6543–6549. doi:10.1016/j.vaccine.2019.08.045.; Matarneh A.S., Al-Battah A.H., Farooqui K, et al. COVID-19 vaccine causing Guillain-Barre syndrome, a rare potential side effect // Clin. Case Rep. 2021. Vol. 9, Nо. 9. e04756. doi:10.1002/ccr3.4756.; Razok A., Shams A., Almeer A., Zahid M. Post-COVID-19 vaccine Guillain-Barrй syndrome; first reported case from Qatar // Ann. Med. Surg. (Lond) 2021. Nо. 67. P. 102540. doi:10.1016/j.amsu.2021.102540.; Waheed S., Bayas A., Hindi F. et al. Neurological Complications of COVID-19: Guillain-Barre Syndrome Following Pfizer COVID-19 Vaccine // Cureus. 2021. Vol. 13, Nо. 2. e13426. doi:10.7759/cureus.13426.; Hughes D.L., Brunn J.A., Jacobs J. et al. Guillain-Barre syndrome after COVID-19 mRNA vaccination in a liver transplantation recipient with favorable treatment response // Liver Transpl. 2022. Vol. 28, Nо. 1. P. 134–137. doi:10.1002/lt.26279.; Wang Y., Wang Y., Huo L. et al. SARS-CoV-2-associated acute disseminated encephalomyelitis: a systematic review of the literature // J. Neurol. 2022. Vol. 269, Nо. 3. P. 1071–1092. doi:10.1007/s00415-021-10771-8.; Yazdanpanah F., Iranpour P., Haseli S. et al. Acute disseminated encephalomyelitis (ADEM) after SARS- CoV-2 vaccination: a case report // Radio Case Rep. 2022. Vol. 17, Nо. 5. P. 1789–1793. doi:10.1016/j.radcr.2022.03.013.; Lindner G., Ryser B. The syndrome of inappropriate antidiuresis after vaccination against COVID-19: case report // BMC Infect. Dis. 2021. Vol.21, Nо. 1. P. 1000. doi:10.1186/s12879-021-06690-8.; Mira F.S., Costa Carvalho J., de Almeida P.A. et al. A case of acute interstitial nephritis after two doses of the BNT162b2 SARS-CoV-2 vaccine // Int. J. Nephrol. Renovascular. Dis. 2021. Nо. 14. P. 421–426. doi:10.2147/IJNRD.S345898.; Gankam K.F., Decaux G. Hyponatremia and the brain // Kidney Int. Rep. 2018. Vol. 3, No. 1. P. 24–35. doi:10.1016/j.ekir.2017.08.015.; Mehta P.R., Apap M.S., Benger M. et al. Cerebral venous sinus thrombosis and thrombocytopenia after COVID-19 vaccination — a report of two UK cases // Brain Behav. Immun. 2021. Nо. 95. P. 514–517. doi:10.1016/j.bbi.2021.04.006.; Malik B., Kalantary A., Rikabi K., Kunadi A. Pulmonary embolism, transient ischaemic attack and thrombocytopenia after the Johnson & Johnson COVID-19 vaccine // BMJ Case Rep. 2021. Vol. 14, N. 7. e243975. doi:10.1136/bcr-2021-243975.; Wan E.Y.F., Chui C.S.L., Lai F.T.T. et al. Bell’s palsy following vaccination with mRNA (BNT162b2) and inactivated (CoronaVac) SARS-CoV-2 vaccines: a case series and nested case-control study // Lancet Infect. Dis. 2021. Vol. 22, Nо. 1. P. 64–72. doi:10.1016/S1473-3099(21)00451-5.; Peitersen E. Bell’s palsy: the spontaneous course of 2,500 peripheral facial nerve palsies of different etiologies // Acta Otolaryngol. Suppl. 2002. Nо. 549. P. 4–30.; Yiran E.L., Shuyi W., Russel J.R., Jun R. Clinical cardiovascular emergencies and the cellular basis of COVID-19 vaccination: from dream to reality // Int. J. Infect. Dis. 2022. Nо. 124. P. 1–10. doi:10.1016/j.ijid.2022.08.026.; Rosenblatt A.E., Stein S.L. Cutaneous reactions to vaccinations // Clin. Dermatol. 2015. Vol. 33, Nо. 3. P. 327–332. doi:10.1016/j.clindermatol.2014.12.009.; Flordeluna Z., Mesina F.Z. Severe relapsed autoimmune hemolytic anemia after booster with mRNA-1273 COVID-19 vaccine // Hematol. Trans. Cell Therapy. 2022. May 30. doi:10.1016/j.htct.2022.05.001. Online ahead of print.; Cohen S.R., Prussick L., Kahn J.S. et al. Leukocytoclastic vasculitis flare following the COVID-19 vaccine // Int. J. 2021. Vol. 60, Nо. 8. P. 1032–1033. doi:10.1111/ijd.15623.; Russo R., Cozzani E., Micalizzi C., Parodi A. Chilblain-like Lesions after COVID-19 Vaccination: A Case Series // Acta Derma. Venereologica. 2022. Nо. 102. adv00711. doi:10.2340/actadv.v102.2076.; Fiorillo G., Pancetti S., Cortese A. et al. Leukocytoclastic vasculitis (cutaneous small-vessel vasculitis) after COVID-19 vaccination // J. Autoimmun. 2022. Nо. 127. P. 102783. doi:10.1016/j.jaut.2021.102783.; Chaurasia B., Chavda V., Lu B. et al. Cognitive deficits and memory impairments after COVID-19 (Covishield) vaccination // Brain Behav. Immun. Health. 2022. Nо. 22. P. 100463. doi:10.1016/j.bbih.2022.100463.; Pilishvili T., Gierke R., Fleming D.K.E. et al. Effectiveness of mRNA COVID-19 vaccine among U.S. Health care personnel // N. Engl. J. Med. 2021. Vol. 385, Nо. 25. e90. doi:10.1056/NEJMoa2106599.; Dutta S., Kaur R., Charan J. et al. Analysis of neurological adverse events reported in VigiBase from COVID-19 vaccines // Cureus. 2022. Vol. 14, Nо. 1. e21376. doi:10.7759/cureus.21376.; 43.Polack F.P., Thomas S.J., Kitchin N. et al. Safety and efficacy of the BNT162b2 mRNA COVID-19 vaccine // N. Engl. J. Med. 2020. Vol. 383, Nо. 25. P. 2603–2615.; Elias C., Cardoso P., Goncalves D. et al. Rhabdomyolysis following administration of comirnaty // Eur. J. Case Rep. Intern. Med. 2021. Vol. 8, Nо. 8. P. 002796. doi:10.12890/2021_002796.; Hakroush S., Tampe B. Case report: ANCA-associated vasculitis presenting with rhabdomyolysis and pauci-immune crescentic glomerulonephritis after pfizer-BioNTech COVID-19 mRNA vaccination // Front. Immunol. 2021. Nо. 12. P. 762006. doi:10.3389/fimmu.2021.762006.; Ozonoff A, Nanishi E, Levy O. Bell’s palsy and SARS-CoV-2 vaccines // Lancet Infect. Dis. 2021. Vol. 21, Nо. 4. P. 450–452. doi:10.1016/S1473-3099(21)00076-1.; Angeli F., Reboldi G., Trapasso M. et al. COVID-19, vaccines and deficiency of ACE2 and other angiotensinases. Closing the loop on the «Spike» effect // Eur. J. Intern. Med. 2022. Nо. 103. P. 23–28. doi:10.1016/j.ejim.2022.06.015.; Mele F., Tafuri S., Stefanizzi P. et al. Cerebral venous sinus thrombosis after COVID-19 vaccination and congenital deficiency of coagulation factors: is there a correlation // Hum. Vaccines & Immunotherapeutic. 2022. Vol. 18, Nо. 6. P. 2095166. doi:10.1080/21645515.2022.2095166.; Nassar M., Chung H., Dhayaparan Y. et al. COVID-19 vaccine induced rhabdomyolysis: case report with literature review // Diabetes Metabol. Syndr. 2021. Vol. 15, Nо. 4. P. 102170. doi:10.1016/j.dsx.2021.06.007.; Ghiasi N., Valizadeh R., Arabsorkhi M. et al. Efficacy and side effects of Sputnik V, Sinophar and AstraZeneca vaccines to stop COVID-19; a review and discussion // Immunopathologia Persa. 2021. Vol. 7, Nо. 2. P. 31. doi:10.34172/ipp.2021.31.; Day B., Menschik D., Thompson D. et al. Reporting Rates for VAERS Death Reports Following COVID-19 Vaccination, December 14, 2020-November 17, 2021 // Pharmacoepidemiol. Drug Saf. 2023. Vol. 32, Nо. 7. P. 763–772. doi:10.1002/pds.5605.; Xu S., Huang R., Sy L.S. et al. COVID-19 Vaccination and Non-COVID-19 Mortality Risk — Seven Integrated Health Care Organizations, United States, December 14, 2020 — July 31, 2021 // MMWR. 2021. Vol. 70, Nо. 43. P. 1520–1524. doi:10.15585/mmwr.mm7043e2.; Xu S., Huang R., Sy L.S. et al. A safety study evaluating non-COVID-19 mortality risk following COVID-19 vaccination // Vaccine. 2023. Vol.41, Nо. 3. P. 844–854. doi:10.1016/j.vaccine.2022.12.036.; Rosenblum H.G., Gee J., Liu R. et al. Safety of mRNA vaccines administered during the initial 6 months of the US COVID-19 vaccination programme: an observational study of reports to the Vaccine Adverse Event Reporting System and v-safe // Lancet Infect. Dis. 2022. Vol. 22, Nо. 6. P. 802–812. doi:10.1016/S1473–3099(22)00054–8.; Montalti M., Solda G., Di Valerio Z. et al. ROCCA observational study: Early results on safety of Sputnik V vaccine (Gam-COVID-Vac) in the Republic of San Marino using active surveillance // eClinicalMedicine. 2021. Nо. 38. P. 101027. doi:10.1016/j.eclinm.2021.101027.; Di Valerio Z., La Fauci G., Sold G. et al. ROCCA cohort study: Nationwide results on safety of Gam-COVID-Vac vaccine (Sputnik V) in the Republic of San Marino using active surveillance // eClinicalMedicine. 2022. Nо. 49. P. 101468. doi:10.1016/j.eclinm.2022.101468.; Hampshire A., Azor A., Atchison C. et al. Cognition and Memory after COVID-19 in a Large Community Sample // N. Engl. J. Med. 2024. Vol.390, Nо. 9. P. 806–818. doi:10.1056/NEJMoa2311330.; Vivaldi G., Pfeffer P.E., Talaei M. et al. Long-term symptom profiles after COVID-19 vs other acute respiratory infections: an analysis of data from the COVIDENCE UK study // eClinicalMedicine. 2023. Nо. 65. P. 102251. doi:10.1016/j.eclinm.2023.102251.; Pagotto V., Ferloni A., Mercedes Soriano M. et al. Active monitoring of early safety of Sputnik V vaccine in Buenos Aires, Argentina // Medicina (B. Aires). 2021. Vol. 81, Nо. 3. Р. 408–414.; European Union risk management plan (EU RMP) for Vaxzevria (ChAdOx1-S [recombinant]). Administrative information. 15.09.2023. 111 p. // URL: https://www.ema.europa.eu/en/documents/rmp-summary/vaxzevria-previously-covid-19-vaccine-astrazeneca-epar-risk-managementplan_en.pdf.; ФМБА заявило о сохранении «МИР 19» эффективности против субвариантов коронавируса FLiRT // ТАСС. 24.05.2024. https://tass.ru/obschestvo/20889607.; Katella K. 3 Things to Know About FLiRT, the New Coronavirus Strains // Yale Medicine. May 21, 2024. URL: https://www.yalemedicine.org/news/3-things-to-know-about-flirt-new-coronavirus-strains.; Роспотребнадзор ведет мониторинг эпидемиологической ситуации поCOVID-19 // Федеральная служба понадзору всфере защиты прав потребителей иблагополучия человека. 22.05.2024. https://rospotrebnadzor.ru/about/info/news/news_details.php?ELEMENT_ID=27703; Сергеева Д. Как российский стартап разработал новую вакцину от коронавируса // РБК. Тренды. 27.12.2021. URL: https://trends.rbc.ru/trends/innovation/61c8f7c49a794755f762a23a.; Проскурнина Е.В., Иванов Д.В., Редько А.А. Осложнения после вакцинации препаратами против SARS-СoV-2: обзор зарубежной литературы // Вестник Санкт-Петербургского университета. Медицина. 2023. Т. 18, вып. 2. С. 112–140. https://doi.org/10.21638/spbu11.2023.202.

  13. 13
    Academic Journal

    Πηγή: General Reanimatology; Том 20, № 5 (2024); 55-69 ; Общая реаниматология; Том 20, № 5 (2024); 55-69 ; 2411-7110 ; 1813-9779

    Περιγραφή αρχείου: application/pdf

    Relation: https://www.reanimatology.com/rmt/article/view/2478/1871; https://www.reanimatology.com/rmt/article/view/2478/1885; https://www.reanimatology.com/rmt/article/downloadSuppFile/2478/1085; https://www.reanimatology.com/rmt/article/downloadSuppFile/2478/1118; Askegard-Giesmann J. R., Caniano D. A., Kenney B. D. Rare but serious complications of central line insertion. Semin Pediatr Surg. 2009; 18 (2): 73–83.; Вартанова И. В., Вартанов В. Я., Родина Н. А. Прикладные анатомо-клинические аспекты катетеризации центральных вен. Санкт-Петербург: Военно-медицинская академия им. С. М. Кирова; 2024: 46–51.; Pittiruti M., Boxtel T. V., Scoppettuolo G., Carr P., Konstantinou E., Miluy G. O., Lamperti M., et al. European recommendations on the proper indication and use of peripheral venous access devices (the ERPIUP consensus): A WoCoVA project. J Vasc Access. 2021: 24 (1): 165–182. DOI:10.1177/11297298211023274. PMID: 34088239.; Seldinger S. I. Catheter replacement of the needle in percutaneous arteriography; a new technique. Acta radiol. 1953; 39 (5): 368–376. DOI:10.3109/00016925309136722. PMID: 13057644.; Каледа В. И. Свен Ивар Сельдингер (1921–1998 гг.) и его метод катетеризации артерий. Диагностическая и интервенционная радиология. 2016; 10 (1): 64–67.; Barone G., Pittiruti M., Biasucci D. G., Elisei D., Iacobone E., La Greca A., Marinosci G. Z., et al. Neo-ECHOTIP: A structured protocol for ultrasound-based tip navigation and tip location during placement of central venous access devices in neonates. J Vasc Access. 2022; 23 (5): 679–688. DOI:10.1177/11297298211007703. PMID: 33818191.; La Greca A., Iacobone E., Elisei D., Biasucci D. G., D’Andrea V., Barone G., Marinosci G. Z., et al. ECHOTIP: A structured protocol for ultrasound-based tip navigation and tip location during placement of central venous access devices in adult patients. J Vasc Access. 2023; 24 (4): 535–544. DOI:10.1177/11297298211044325. PMID: 34494474.; Marinosci G. Z., Biasucci D. G., Barone G., D’Andrea V., Elisei D., Iacobone E., La Greca A., et al. ECHOTIP-Ped: A structured protocol for ultrasound-based tip navigation and tip location during placement of central venous access devices in pediatric patients. J Vasc Access. 2023; 24 (1): 5–13. DOI:10.1177/11297298211031391. PMID: 34256613.; Verma A., Chitransh V., Jaiswal S., Vishen A., Sheikh W. R., Haldar M., Ahuja R., et al. Guidewire entrapped in the right ventricle: a rare complication of hemodialysis catheter insertion. Indian J Crit Care Med. 2020; 24 (1): 80–81. DOI:10.5005/jp-journals-10071-23334. PMID: 32148357.; Unnikrishnan K. P., Sinha P. K., Nalgirkar R. S. An alternative and simple technique of guidewire retrieval in a failed Seldinger technique. Anesth Analg. 2005; 100 (3): 898–899. DOI:10.1213/01.ANE.0000146654.99367.DD. PMID: 15728092.; Park S. K., Yi I.-K., Lee J.-H., Kim D.-H., Lee S.-Y. Fracture of J-tipped guidewire during central venous catheterization and its successful removal under fluoroscopic guidance — a case report. Korean J Anesthesiol. 2012; 63 (5): 457–460. DOI:10.4097/kjae.2012.63.5.457. PMID: 23198042.; McGee D. C., Gould M. K. Preventing complications of central venous catheterization. N Engl J Med. 2003; 348 (12): 1123–1133. DOI:10.1056/NEJMra011883. PMID: 12646670.; Романенко Н. А., Шилова Е. Р., Алборов А. Э., Волошин С. В., Чеботкевич В. Н. Тромботические, геморрагические и другие осложнения, констатируемые в процессе и после катетеризаций центральной вены у пациентов онкогематологического профиля. Вестник Гематологии. 2020; 16 (4): 54–55.; Быков М. В. Ультразвуковые исследования в обеспечении инфузионной терапии в отделениях реанимации и интенсивной терапии. Тверь: ООО «Издательство «Триада»; 2011: 36.; Soleimanpour H. Inadvertent arterial puncture during central venous catheter insertion. Ann Clin Anal Med. 2016; 7 (161). DOI:10.4328/JCAM.1699; Wierstra B., Au S. S., Cantle P. M., Romens K. Arterial placement of central venous catheters: beyond prevention to management. Can J Gen Intern Med. 2020; 159 (3): 45–48.; Saugel B., Scheeren T. W. L., Teboul J.-L. Ultrasound-guided central venous catheter placement: a structured review and recommendations for clinical practice. Crit Care. 2017; 21 (1): 225. DOI:10.1186/s13054-017-1814-y. PMID: 28844205.; Wang L., Liu Z.-S., Wang C.-A. Malposition of central venous catheter: Presentation and management. Chin Med J (Engl). 2016: 129 (2): 227–234. DOI:10.4103/0366-6999.173525. PMID: 26830995.; Chen W.-M., Chiang M.-S., Wang P. C., Wei K.-L., Tung S.-Y., Chang T. S., Hung C.-H. Esophageal perforation caused by a central venous catheter: A case report and literature review. Adv Dig Med. 2020; 7 (2): 93–96. DOI:10.1002/aid2.13160.; Kayashima K. Evaluation of mechanical complications during pediatric central venous catheter placement from 1994 to 2013. Int J Anesthesiol Res. 2013; 1 (1): 34–36. DOI:10.14205/2310-9394.2013.01.01.5; Karapinar B., Cura A. Complications of central venous catheterization in critically ill children. Pediatr Int. 2007; 49 (5): 593–599. DOI:10.1111/j.1442-200X.2007.02407.x.PMID: 17875082.; Yelgeç N. S., Osken A., Turkkan C., Alper A. T. Subclavian vein puncture-induced massive pulmonary hemorrhage and hemoptysis during pacemaker implantation. North Clin Istanb. 2018; 5 (3): 254–255. DOI:10.14744/nci.2017.86619.PMID: 30688923.; Bagchi A., Agarwal R. K., Talwar K. K. Hemoptysis after subclavian vein puncture for pacemaker implantation: a case report. J Cardiol Cardiovasc Med. 2019; 4 (3): 192–194. DOI:10.29328/journal.jccm.1001065.; Bawa A. S., Jain V., Gutierrez G. Local pulmonary hemorrhage as a complication of subclavian vein catheterization. Chest. 2007; 132 (4): 695A. DOI:10.1378/chest.132.4_MeetingAbstracts.695a; Goldberg A., Rosenfeld I., Marmor A. Hemoptysis — a rare complication of pacemaker implantation. Indian Pacing Electrophysiol J. 2008; 8 (1): 75–76. PMID: 18270606.; Kossaify A., Nicolas N., Edde P. Hemoptysis after subclavian vein puncture for pacemaker implantation: importance of wire-guided venous puncture. Clin Med Insights Case Rep. 2012; 5: 119–122. DOI:10.4137/CCRep.S10006. PMID: 22859867.; Truong A. T., Brown D. L. Catastrophic hemothorax from lobar pulmonary artery puncture during attempted subclavian vein catheterization: the fallibility of venous blood aspiration. J Clin Anesth. 2009; 21 (5); 377–378. DOI:10.1016/j.jclinane.2008.10.005. PMID: 19700295.; Horner F. On a form of ptosis. Arch Neurol. 1968; 19 (5): 541–542. 10.1001/archneur.1968.00480050111013.; Khan T. A., Zameer S., Ijaz U., Zahid M. A., Zameer N. U. A. Iatrogenic Horner’s syndrome after insertion of a central venous catheter: recommendations for clinical practice. Egypt J Intern Med. 2022; 34 (1): 55. DOI:10.1186/s43162-022-00144-6; Zou Z. Y., Yao Y. T. Horner syndrome caused by internal jugular vein catheterization. J Cardiothorac Vasc Anesth. 2020; 34 (6): 1636–1640. DOI:10.1053/j.jvca.2019.06.031. PMID: 31350153.; Narouze S., Vydyanathan A., Patel N. Ultrasound-guided stellate ganglion block successfully prevented esophageal puncture. Pain Physician. 2007; 10 (6): 747–752. PMID: 17987096.; Paraskevas G. K., Raikos A., Chouliaras K., Papaziogas B. Variable anatomical relationship of phrenic nerve and subclavian vein: clinical implication for subclavian vein catheterization. Br J Anaesth. 2011; 106 (3): 348–351. DOI:10.1093/bja/aeq373. PMID: 21233111.; Takasaki Y., Arai T. Transient right phrenic nerve palsy associated with central venous catheterization. Br J Anaesth. 2001; 87 (3): 510–511. DOI:10.1093/bja/87.3.510. PMID: 11517143.; Быков М. В., Лазарев В. В., Багаев В. Г., Мадорский К. С., Быкова Л. В. Повреждение блуждающего нерва при пункции и катетеризации внутренней яремной вены — одно из редко выявляемых осложнений катетеризации центральных вен. Российский вестник детской хирургии анестезиологии и реаниматологии. 2017; 7 (3): 54–62. DOI:10.17816/psaic334.; Leone V., Misuri D., Console N. Radial artery pseudoaneurysm after a single arterial puncture for blood-gas analysis: a case report. Cases J. 2009; 2: 6890. DOI:10.4076/1757-1626-2-6890. PMID: 19829877.; Levis J. T., Garmel G. M. Radial artery pseudoaneurysm formation after cat bite to the wrist. Ann Emerg Med. 2008; 51 (5): 668–670. DOI:10.1016/j.annemergmed.2007.11.031. PMID: 18325629.; Eisenberg L., Paulson E. K., Kliewer M. A., Hudson M. P., DeLong D. M., Carroll B. A. Sonographically guided compression repair of pseudoaneurysms: further experience from a single institution. AJR Am J Roentgenol. 1999; 173 (6): 1567–1573. DOI:10.2214/ajr.173.6.10584803.PMID: 10584803; Lenartova M., Tak T. Iatrogenic pseudoaneurysm of femoral artery: case report and literature review. Clin Med Res. 2003; 1 (3): 243–247. DOI:10.3121/cmr.1.3.243. PMID: 15931315.; Mol T. N., Gupta A., Narain U. Brachial plexus compression due to subclavian artery pseudoaneurysm from internal jugular vein catheterization. Indian J Nephrol. 2017; 27 (2): 148–150. DOI:10.4103/0971-4065.179334. PMID: 28356671.; Al-Thani H., Hussein A., Sadek A., Barah A., El-Menyar A. Balloonassisted percutaneous thrombin injection for treatment of iatrogenic left subclavian artery pseudoaneurysm in a critically ill COVID-19 patient. Case Rep Vasc Med. 2021; 2021: 4245484. DOI:10.1155/2021/4245484. PMID: 34659861.; Weger N., Klaassen Z., Slurt C., Hertz S. Endovascular treatment of a pseudoaneurysm after an iatrogenic axillary artery injury. Ann Vasc Surg. 2010; 24 (6): 826. e9–12. DOI:10.1016/j.avsg.2009.12.019. PMID: 20471203.; Balethbail S., Singha S. K., Gayatri P. Vertebral artery pseudoaneurysm a complication after attempted internal jugular vein catheterization in a neurosurgical patient. J Neurosurg. Anesthesiol. 2011; 23 (1): 53. DOI:10.1097/ANA.0b013e3181f20616. PMID: 21252709.; Scholten H. J. Pourtaherian A., Mihajlovic N., Korsten H. H. M., Bouwman R. A. Improving needle tip identification during ultrasound-guided procedures in anaesthetic practice. Anaesthesia. 2017; 72 (7): 889–904. DOI:10.1111/anae.13921. PMID: 28542716.; Лахин Р. Е., Антипин Э. Э., Баутин А. Е., Корячкин В. А., Уваров Д. Н., Теплых Б. А., Ульрих Г. Э., с соавт. Клинические рекомендации по катетеризация сосудов под контролем ультразвука. Общероссийская общественная организация «Федерация Анестезиологов и Реаниматологов». 2015. eLIBRARY ID: 26002350.; https://www.reanimatology.com/rmt/article/view/2478

  14. 14
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20
    Academic Journal

    Πηγή: Mother and Baby in Kuzbass; № 3 (2023): сентябрь; 17-23 ; Мать и Дитя в Кузбассе; № 3 (2023): сентябрь; 17-23 ; 2542-0968 ; 1991-010X

    Περιγραφή αρχείου: text/html; application/pdf